Hematological biomarkers have emerged as powerful tools in diagnosing Acute Heart Failure (AHF). This study introduces a novel diagnostic framework that integrates Explainable Artificial Intelligence (XAI) with Morris Sensitivity Analysis (MSA) to enhance both the interpretability and performance of machine learning models in AHF detection. A dataset consisting of 425 AHF patients and 430 controls was analyzed using eight machine learning models, including XGBoost, Histogram-based Gradient Boosting (histGB), Explainable Boosting Machine (EBM), and Random Forest. Model performance was evaluated through metrics such as AUC, accuracy, precision, recall, and Brier score. Hyperparameters were optimized via Bayesian optimization. Feature importance was assessed using MSA to identify variables with the highest predictive influence. The histGB model achieved the highest performance with an AUC of 87.93%. Both MSA and EBM consistently identified PDW, RDW-CV, NEU, NEU/LY ratio, age, and WBC as top predictive features across multiple models. These hematological markers demonstrated strong potential for early diagnosis and risk stratification in AHF patients. This study presents a clinically relevant, interpretable, and cost-effective diagnostic strategy that combines XAI with MSA for AHF prediction. The framework enhances clinical trust and provides a pathway toward personalized treatment by identifying accessible hematological biomarkers. The integration of explainability into AI models improves their transparency and applicability in real-world clinical settings.
Frontiers in Public Health · مجلد 12 · 1462693-1462693
Fetal health holds paramount importance in prenatal care and obstetrics, as it directly impacts the wellbeing of mother and fetus. Monitoring fetal health through pregnancy is crucial for identifying and addressing potential risks and complications that may arise. Early detection of abnormalities and deviations in fetal health can facilitate timely interventions to mitigate risks and improve outcomes for the mother and fetus. Monitoring fetal health also provides valuable insights into the effectiveness of prenatal interventions and treatments. For fetal health classification, this research work makes use of cardiotocography (CTG) data containing 21 features including fetal growth, development, and physiological parameters such as heart rate and movement patterns with three target classes "normal," "suspect," and "pathological." The proposed methodology makes use of data upsampled using the synthetic minority oversampling technique (SMOTE) to handle the class imbalance problem that is very crucial in medical diagnosing with a light gradient boosting machine. The results show that the proposed model gives 0.9989 accuracy, 0.9988 area under the curve, 0.9832 recall, 0.9834 precision, 0.9832 F1 score, 0.9748 Kappa score, and 0.9749 Matthews correlation coefficient value on the test dataset. The performance of the proposed model is compared with other machine learning models to show the dominance of the proposed model. The proposed model's significance is further evaluated using 10-fold cross-validation and comparing the proposed model with other state-of-the-art models.
fetal health classificationcardiotocographyLightGBMSHAP explainable AI
Phishing, an Internet fraud where individuals are deceived into revealing critical personal and account information, poses a significant risk to both consumers and web-based institutions. Data indicates a persistent rise in phishing attacks. Moreover, these fraudulent schemes are progressively becoming more intricate, thereby rendering them more challenging to identify. Hence, it is imperative to utilize sophisticated algorithms to address this issue. Machine learning is a highly effective approach for identifying and uncovering these harmful behaviors. Machine learning (ML) approaches can identify common characteristics in most phishing assaults. In this paper, we propose an ensemble approach and compare it with six machine learning techniques to determine the type of website and whether it is normal or not based on two phishing datasets. After that, we used the normalization technique on the dataset to transform the range of all the features into the same range. The findings of this paper for all algorithms are as follows in the first dataset based on accuracy, precision, recall, and F1-score, respectively: Decision Tree (DT) (0.964, 0.961, 0.976, 0.968), Random Forest (RF) (0.970, 0.964, 0.984, 0.974), Gradient Boosting (GB) (0.960, 0.959, 0.971, 0.965), XGBoost (XGB) (0.973, 0.976, 0.976, 0.976), AdaBoost (0.934, 0.934, 0.950, 0.942), Multi Layer Perceptron (MLP) (0.970, 0.971, 0.976, 0.974) and Voting (0.978, 0.975, 0.987, 0.981). So, the Voting classifier gave the best results. While in the second dataset, all the algorithms gave the same results in four evaluation metrics, which indicates that each of them can effectively accomplish the prediction process. Also, this approach outperformed the previous work in detecting phishing websites with high accuracy, a lower false negative rate, a shorter prediction time, and a lower false positive rate.
BACKGROUND: This study aims to identify unique metabolomics biomarkers associated with Type 2 Diabetes (T2D) and develop an accurate diagnostics model using tree-based machine learning (ML) algorithms integrated with bioinformatics techniques. METHODS: Univariate and multivariate analyses such as fold change, a receiver operating characteristic curve (ROC), and Partial Least-Squares Discriminant Analysis (PLS-DA) were used to identify biomarker metabolites that showed significant concentration in T2D patients. Three tree-based algorithms [eXtreme Gradient Boosting (XGBoost), Light Gradient Boosting Machine (LightGBM), and Adaptive Boosting (AdaBoost)] that demonstrated robustness in high-dimensional data analysis were used to create a diagnostic model for T2D. RESULTS: As a result of the biomarker discovery process validated with three different approaches, Pyruvate, D-Rhamnose, AMP, pipecolate, Tetradecenoic acid, Tetradecanoic acid, Dodecanediothioic acid, Prostaglandin E3/D3 (isobars), ADP and Hexadecenoic acid were determined as potential biomarkers for T2D. Our results showed that the XGBoost model [accuracy = 0.831, F1-score = 0.845, sensitivity = 0.882, specificity = 0.774, positive predictive value (PPV) = 0.811, negative-PV (NPV) = 0.857 and Area under the ROC curve (AUC) = 0.887] had the slight highest performance measures. CONCLUSIONS: ML integrated with bioinformatics techniques offers accurate and positive T2D candidate biomarker discovery. The XGBoost model can successfully distinguish T2D based on metabolites.
type 2 diabetesmetabolomics biomarkersmetabolic signaturesXGBoost
Addressing the pressing challenge of insurance fraud, which significantly impacts financial losses and trust within the insurance industry, this study introduces an innovative automated detection system utilizing ensemble machine learning (EML) algorithms. The approach encompasses four strategic phases: 1) Tackling data imbalance through diverse re-sampling methods (Over-sampling, Under-sampling, and Hybrid); 2) Optimizing feature selection (Filtering, Wrapping, and Embedding) to enhance model accuracy; 3) employing binary classification techniques (Bagging and Boosting) for effective fraud identification; and 4) applying explanatory model analysis (Shapley Additive Explanations, Break-down plot, and variable-importance Measure) to evaluate the influence of individual features on model performance. Our comprehensive analysis reveals that while not every re-sampling technique improves model performance, all feature selection methods markedly bolster predictive accuracy. Notably, the combination of the Gradient Boosting Machine (GBM) algorithm with NCR re-sampling and GBMVI feature selection emerges as the most effective configuration, offering superior fraud detection capabilities. This study not only advances the theoretical framework for combating insurance fraud through AI but also provides a practical blueprint for insurance companies aiming to incorporate advanced AI strategies into their fraud detection arsenals, thereby mitigating financial risks and fostering trust systems.
Accurate and rapid diagnosis is essential in the healthcare system for the detection of strokes to mitigate the devastating effects. This study introduces an innovative model for identifying strokes using advanced deep learning (DL) architectures, including SqueezeNet v1.1 and MobileNet V3-Small, feature fusion approaches, and CatBoost models. Using SqueezeNet v1.1 and MobileNet V3-Small, the authors extract meaningful features from computed tomography images that capture local details and global patterns suggesting stroke conditions. Subsequently, they employ feature fusion to combine the complementary representations derived by both architectures, consequently boosting the discriminative capability of the feature set. The Optuna-based CatBoost model is employed to predict stroke using the fused features. The experimental findings show outstanding performance, with a considerable accuracy of 99.1%. The high accuracy level demonstrates our suggested method’s effectiveness in precisely detecting strokes from medical imaging data. Combining DL architectures, feature fusion, and gradient-boosting models offers a promising approach to enhancing stroke diagnosis systems. This can potentially improve patient outcomes and clinical decision-making in stroke treatment.